Description

4-(6-([(4-Chlorophenyl)Sulfinyl]Methyl)-2-Phenyl-4-Pyrimidinyl)Morpholine is a high-purity, advanced pharmaceutical intermediate characterized by its complex heterocyclic structure incorporating a sulfinyl linkage. This compound is of significant value in medicinal chemistry research and development, particularly for its role as a key building block in the synthesis of novel therapeutic agents. It is primarily required by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in developing new drug candidates, especially within oncology and targeted therapy pipelines.

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the multi-step synthesis of potential drug candidates, particularly kinase inhibitors.
• Medicinal Chemistry Research: Used as a scaffold or building block for structure-activity relationship (SAR) studies to optimize biological activity and pharmacokinetic properties.
• Biochemical Tool Compound: Employed in vitro and in vivo to study specific biological pathways and target validation.
• Fine Chemical Synthesis: Utilized in custom synthesis and contract manufacturing organizations (CMOs) for producing high-value, low-volume specialty chemicals.
• Academic Research: Used in university and institutional labs for exploratory research in organic synthesis and drug discovery methodologies.

Basic Information

Product Name	4-(6-([(4-Chlorophenyl)Sulfinyl]Methyl)-2-Phenyl-4-Pyrimidinyl)Morpholine
CAS No.	306980-67-6
Molecular Formula	C21H20ClN3O2S
Molecular Weight	413.92 g/mol
Synonyms	4-[6-[[(4-Chlorophenyl)sulfinyl]methyl]-2-phenyl-4-pyrimidinyl]morpholine; 4-(6-((4-Chlorophenyl)sulfinyl)methyl)-2-phenylpyrimidin-4-yl)morpholine; 306980-67-6; 4-(6-{[(4-Chlorophenyl)sulfinyl]methyl}-2-phenyl-4-pyrimidinyl)morpholine; Morpholine, 4-[6-[[(4-chlorophenyl)sulfinyl]methyl]-2-phenyl-4-pyrimidinyl]-
EINECS	Contact for details

Quality Control

Our 4-(6-([(4-Chlorophenyl)Sulfinyl]Methyl)-2-Phenyl-4-Pyrimidinyl)Morpholine is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing to ensure identity, purity, and consistency, meeting the stringent requirements for pharmaceutical R&D. A comprehensive Certificate of Analysis (COA) detailing purity (typically ≥95% by HPLC), identity confirmation, and impurity profile is provided with every shipment to support your quality and regulatory documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at a controlled room temperature (15-25°C). The compound may be light-sensitive and hygroscopic; therefore, containers should be kept sealed under an inert atmosphere when not in use to maintain stability and prevent degradation.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 95.0%
Related Substances (HPLC)	Any single impurity ≤ 1.0%
Total Impurities	≤ 5.0%
Loss on Drying	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.